Democratizing hedge fund level analysis tools for everyone
| Name | Merck Tbk. |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| Merck Holding Gmbh | 73.99 | 73.99 |
| Public < 5% | 13.35 | 13.35 |
| Emedia Export Company Mbh | 12.66 | 12.66 |
| Treasury Shares | 0.0 | 0.0 |
| Source | 2022 | 2021 |
|---|---|---|
| 2372 | MERK | F2 |
| 2373 | MERK | F2 |
| 2374 | MERK | F2 |
| 2375 | MERK | F2 |
| 2376 | MERK | F2 |
| Region | 2022 | 2021 |
|---|---|---|
| 1429 | MERK | F2 |
| 1430 | MERK | F2 |
| 1431 | MERK | F2 |
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 1.41 | # 12 / 15 |
| EV_EBITDA | 4.97 | # 4 / 15 |
| PER | 7.94 | # 3 / 15 |
| PBV | 1.74 | # 11 / 15 |
| DER | 0.00 | # 2 / 15 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | 17.735447888486 | # 2 / 15 |
| ROA % | 18.21 | # 2 / 15 |
| ROE % | 21.91 | # 2 / 15 |
| Year | DPS | Yield [%] |
|---|---|---|
| 2026 | 275.0 | 6.9 |
| 2025 | 170.0 | 5.1 |
| 2024 | 320.0 | 8.9 |
| 2023 | 320.0 | 7.7 |
| 2022 | 240.0 | 5.1 |
| 2021 | 122.0 | 3.3 |
| 2020 | 130.0 | 4.0 |
| 2019 | 0.0 | 0.0 |
| Timeframe | Performance |
|---|---|
| 1W % | 0.8 |
| 1Mo % | 6.2 |
| 3Mo % | 7.1 |
| 1Yr % | 39.9 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| KLBF | 9.63 | 36.98 T | 32.98 T | 38,958 B | 5,365 B | 3,839 B |
| SOHO | 20.50 | 15.29 T | 14.58 T | 10,725 B | 980 B | 746 B |
| TSPC | 8.24 | 12.76 T | 8.61 T | 14,220 B | 1,885 B | 1,550 B |
| SIDO | 16.01 | 10.68 T | 10.21 T | 2,933 B | 959 B | 667 B |
| MDLA | 6.59 | 2.91 T | 2.75 T | 16,342 B | 643 B | 442 B |
| KAEF | 123.99 | 2.56 T | 8.59 T | 9,403 B | 627 B | 21 B |